Cellectar Biosciences, Inc. · NASDAQ:CLRB
Longcor Jarrod bought 8,680 Cellectar Biosciences, Inc. shares (Form 4)
Traded May 7, 2026 · Filed May 11, 2026
On May 7, 2026, Longcor Jarrod (Chief Operating Officer) bought 8,680 Cellectar Biosciences, Inc. shares at US$2.88 for US$24,998, leaving 20,451 shares. Filed May 11, 2026 (Form 4).
- Bought
- 8,680 shares
- Price
- US$2.88
- Value
- US$24,998
- Holding after
- 20,451 shares
- Trading plan
- No
- Role
- Chief Operating Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 7, 2026 | Common Stock | Buy | 8,680 | US$2.88 | 20,451 | Direct |
Source
Related
- Cellectar Biosciences, Inc.
- Longcor Jarrod
- Cellectar Biosciences, Inc. shareholders
- Schedule 13G · Stempoint Capital LP · Aug 14, 2026
- Schedule 13G · Silverarc Capital Management, LLC · Aug 14, 2026
- Schedule 13G · Balyasny Asset Management L.P. · Aug 14, 2026
- Schedule 13G · Caligan Partners LP · Aug 14, 2026
- Schedule 13G · Bleichroeder LP · Aug 13, 2026